Immunization by intramuscular injection of plasmid DNA expressing mycobacterial 65-kDa heat shock protein (hsp65) protects mice against challenge with virulent
Mycobacterium tuberculosis H37Rv. During infection or after immunization, CD4
+/CD8
− and CD8
+/CD4
− hsp65-reactive T cells increased equally in spleens. During infection, the majority of these cells were weakly CD44 positive (CD44
lo) and produced interleukin 4 (IL-4) whereas after immunization the majority were highly CD44 positive (CD44
hi) and produced gamma interferon (IFN-γ). In adoptive transfer of protection to naive mice, the total CD8
+/CD4
− cell population purified from spleens of immunized mice was more protective than that from infected mice. When the cells were separated into CD4
+/CD8
− and CD8
+/CD4
− types and then into CD44
hi and CD44
lo types, CD44
lo cells were essentially unable to transfer protection, the most protective CD44
hi cells were CD8
+/CD4
−, and those from immunized mice were much more protective than those from infected mice. Thus, whereas the CD44
lo IL-4-producing phenotype prevailed during infection, protection was associated with the CD8
+/CD44
hi IFN-γ-producing phenotype that predominated after immunization. This conclusion was confirmed and extended by analysis of 16 hsp65-reactive T-cell clones from infected mice and 16 from immunized mice; the most protective clones, in addition, displayed antigen-specific cytotoxicity.Tuberculosis is a classic example of an infectious disease in which the disease process is caused by the immune response directed at the infectious agent. The bacteria and their products are, in themselves, not very toxic, and the extensive tissue damage, wasting, and death of the diseased individual largely constitute the immunopathology of the cell-mediated immune response. Nevertheless, it is also the cell-mediated response that protects against the disease by arresting, killing, and removing the multiplying bacteria. Whether this protective effect occurs early or late, and temporarily or permanently, determines disease progression by regulating the supply of antigen that drives the immunopathology. An important question that arises from this balance between the protective and harmful effects of the immune response is whether the antigens and immune responses that protect can be distinguished from those that harm. If so, they might be separately manipulated in new vaccines or in immunotherapy of the disease.The T lymphocytes that regulate cellular immunity can be divided not only into the CD4
+/CD8
− and CD8
+/CD4
− phenotypes that primarily recognize exogenous and endogenous antigens, respectively (
8), or into activated (memory) and nonactivated cells according to highly CD44-positive (CD44
hi) and weakly CD44-positive (CD44
lo) expression (
5) but also into two major functionally distinct types on the basis of the profiles of cytokines that they produce. Type 1 cells (Th1 or TC1) favor development of cellular immunity (typified by gamma interferon [IFN-γ], interleukin 2 [IL-2], and IL-12 production). Type 2 cells (Th2 or TC2) favor development of antibody response (typified by IL-4, IL-6, and IL-10 production). Each type promotes differentiation of precursors into the same phenotype and inhibits development of the other phenotype (
2,
27), and in consequence the type of response initiated in a microenvironment tends to be self-sustaining. IFN-γ is essential for the development of protective immunity (
38) and is probably the most important factor that activates macrophages for antimycobacterial action, at least in mice (
13,
34,
35). Therefore protection would be expected to be associated with an immune response in which the type 1 cytokine profile predominated. We have found that immunization procedures that present mycobacterial hsp65 to the immune system as an endogenous antigen generate strong protection against tuberculosis challenge and that this is associated with the presence of a splenic T-cell population in which CD8
+/CD44
hi IFN-γ-producing cytotoxic cells are prominent (
28a). However, cells with a type 2 profile are also present in substantial numbers following infection (
22,
39) or
Mycobacterium bovis BCG vaccination (
24), and the question of what contribution the other phenotypes make to protection arises. To help to answer this question we have used here the combined approaches of comparing the frequency of the different phenotypes in spleens of hsp65 DNA-vaccinated and
Mycobacterium tuberculosis-infected mice and testing the different phenotypes, either as purified subpopulations or as T-cell clones, in adoptive transfer of protection.
相似文献